应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03320 华润医药
休市中 11-22 16:08:13
5.180
-0.150
-2.81%
最高
5.370
最低
5.140
成交量
1,267万
今开
5.320
昨收
5.330
日振幅
4.32%
总市值
325.43亿
流通市值
325.43亿
总股本
62.83亿
成交额
6,618万
换手率
0.20%
流通股本
62.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
华润医药11月22日遭主力抛售65万元 环比增加306.25%
市场透视 · 11-22 16:16
华润医药11月22日遭主力抛售65万元 环比增加306.25%
华润医药(03320.HK)附属内部重组
阿斯达克财经 · 11-22 10:02
华润医药(03320.HK)附属内部重组
华润医药拟售华润圣火51%股权 交易价17.91亿元
财中社 · 11-21 20:22
华润医药拟售华润圣火51%股权 交易价17.91亿元
华润医药(03320):华润三九(000999.SZ)将向昆药(600422.SH)出售华润圣火51%权益
智通财经 · 11-21 18:23
华润医药(03320):华润三九(000999.SZ)将向昆药(600422.SH)出售华润圣火51%权益
高盛:予华润医药“中性”评级 目标价降至6.11港元
新浪港股 · 11-20 11:50
高盛:予华润医药“中性”评级 目标价降至6.11港元
博雅生物解除华润医药控股15.53%限售股份
财中社 · 11-19
博雅生物解除华润医药控股15.53%限售股份
华润医药11月19日获主力加仓383万元 环比增加378.75%
市场透视 · 11-19
华润医药11月19日获主力加仓383万元 环比增加378.75%
华润医药(03320.HK)治疗角结膜上皮损伤药物通过国家药监局一致性评价
阿斯达克财经 · 11-19
华润医药(03320.HK)治疗角结膜上皮损伤药物通过国家药监局一致性评价
华润医药11月15日遭主力抛售181万元 环比增加4425.00%
市场透视 · 11-15
华润医药11月15日遭主力抛售181万元 环比增加4425.00%
华润医药(03320.HK)旗下利格列汀原料药获化学原料药上市申请批准通知书
阿斯达克财经 · 11-14
华润医药(03320.HK)旗下利格列汀原料药获化学原料药上市申请批准通知书
华润医药11月13日主力资金流入237万元 连续5日加仓
市场透视 · 11-13
华润医药11月13日主力资金流入237万元 连续5日加仓
华润医药旗下华润堂关闭香港分店,内地业务此前已被分拆
新京报网 · 11-12
华润医药旗下华润堂关闭香港分店,内地业务此前已被分拆
华润医药11月12日获主力加仓264万元 环比增加306.15%
市场透视 · 11-12
华润医药11月12日获主力加仓264万元 环比增加306.15%
华润医药(03320.HK)旗下氨氯地平阿托伐他汀钙片补充申请获批
阿斯达克财经 · 11-12
华润医药(03320.HK)旗下氨氯地平阿托伐他汀钙片补充申请获批
光大证券:赋能商业健康险促进支付多元化 医保预付缓解垫资压力
智通财经 · 11-12
光大证券:赋能商业健康险促进支付多元化 医保预付缓解垫资压力
华润医药11月11日主力资金流入65万元 连续3日加仓
市场透视 · 11-11
华润医药11月11日主力资金流入65万元 连续3日加仓
华润医药附属完成收购Green Cross HK的100%权益
新浪港股 · 11-07
华润医药附属完成收购Green Cross HK的100%权益
华润医药(03320)附属完成收购Green Cross HK的100%权益
智通财经 · 11-06
华润医药(03320)附属完成收购Green Cross HK的100%权益
华润医药10月31日主力资金流出130万元 连续3日减仓
市场透视 · 10-31
华润医药10月31日主力资金流出130万元 连续3日减仓
华润医药(03320.HK)附属东阿阿胶首九个月赚11.52亿人民币 增长46.7%
阿斯达克财经 · 10-31
华润医药(03320.HK)附属东阿阿胶首九个月赚11.52亿人民币 增长46.7%
暂无数据
公司概况
公司名称:
华润医药
所属市场:
SEHK
上市日期:
--
主营业务:
华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。
发行价格:
--
{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":5.18,"timestamp":1732262893017,"preClose":5.33,"halted":0,"volume":12665100,"delay":0,"floatShares":6282510461,"shares":6282510461,"eps":0.65799457,"marketStatus":"休市中","marketStatusCode":7,"change":-0.15,"latestTime":"11-22 16:08:13","open":5.32,"high":5.37,"low":5.14,"amount":66181510,"amplitude":0.043152,"askPrice":5.18,"askSize":51000,"bidPrice":5.17,"bidSize":22500,"shortable":3,"etf":0,"ttmEps":0.6365436589622825,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"listingDate":1477584000000,"adjPreClose":5.33,"dividendRate":0.049084,"openAndCloseTimeList":[[1732239000000,1732248000000],[1732251600000,1732262400000]],"volumeRatio":1.938272,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320/tweets","defaultTab":"tweets","newsList":[{"id":"2485233384","title":"华润医药11月22日遭主力抛售65万元 环比增加306.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485233384","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485233384?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:16","pubTimestamp":1732263402,"startTime":"0","endTime":"0","summary":"11月22日, 华润医药股价跌2.81%,报收5.18元,成交金额6618万元,换手率0.20%,振幅4.32%,量比1.93。华润医药今日主力资金净流出65万元,连续3日净流出,上一交易日主力净流出16万元,今日环比增加306.25%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为52.63%,平均跌幅为1.81%。该股近5个交易日下跌3.35%,主力资金累计净流入371万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入503万元,其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122161737a24d65fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122161737a24d65fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2485470475","title":"华润医药(03320.HK)附属内部重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2485470475","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485470475?lang=zh_cn&edition=full","pubTime":"2024-11-22 10:02","pubTimestamp":1732240920,"startTime":"0","endTime":"0","summary":"华润医药公布,其非全资附属华润圣火建议内部重组。据此,公司间接非全资附属昆药,向公司间接非全资附属华润三九收购华润圣火51%权益,总代价为17.91亿元人民币,料华润三九将使用所得款项补充其营运资金。于建议内部重组完成后,预期公司于华润圣火持有的权益将由约63.02%摊薄至约39.9%,而华润圣火将仍为公司之非全资附属。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1398728/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2485498899","title":"华润医药拟售华润圣火51%股权 交易价17.91亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485498899","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485498899?lang=zh_cn&edition=full","pubTime":"2024-11-21 20:22","pubTimestamp":1732191757,"startTime":"0","endTime":"0","summary":"财中社11月21日电华润医药(03320)发布关于涉及公司非全资附属公司昆明华润圣火药业有限公司的建议内部重组的最新信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411213246946649.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2485635764","title":"华润医药(03320):华润三九(000999.SZ)将向昆药(600422.SH)出售华润圣火51%权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2485635764","media":"智通财经","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485635764?lang=zh_cn&edition=full","pubTime":"2024-11-21 18:23","pubTimestamp":1732184633,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药 发布公告,于2024年11月21日,华润三九与昆药订立股权转让协议,华润三九已有条件同意出售,及昆药已有条件同意收购华润圣火51%权益,总代价为人民币17.91亿元。预计华润三九将使用出售华润圣火 51%权益的所得款项补充其营运资金。华润三九为本公司的间接非全资附属公司,于本公告日期,由本公司拥有约63.02% 权益,及华润三九的股份于深圳证券交易所上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1214136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000999","BK0012","BK0185","BK0239","BK1570","BK0183","BK1191","BK0010","600422","03320","BK0175","BK0188","BK0196","BK0028","BK0060"],"gpt_icon":0},{"id":"2484134987","title":"高盛:予华润医药“中性”评级 目标价降至6.11港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484134987","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484134987?lang=zh_cn&edition=full","pubTime":"2024-11-20 11:50","pubTimestamp":1732074600,"startTime":"0","endTime":"0","summary":" 高盛发布研究报告称,下调华润医药目标价1.6%,从6.21港元降至6.11港元,评级“中性”。高盛略微下调对该公司2024、2025和2026年盈利预测1.2%、1.8%和2.3%,反映制药业务差于预期以及药品分销复苏缓慢。 报告中称,华润医药子公司数据显示,阿胶表现好于VBPed,处方药持续疲软,分销药品恢复疲软。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2024-11-20/doc-incwspwu2286841.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2024-11-20/doc-incwspwu2286841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["03320"],"gpt_icon":0},{"id":"2484911369","title":"博雅生物解除华润医药控股15.53%限售股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2484911369","media":"财中社","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484911369?lang=zh_cn&edition=full","pubTime":"2024-11-19 17:56","pubTimestamp":1732010171,"startTime":"0","endTime":"0","summary":"本次申请解除限售股份为公司向特定对象华润医药控股有限公司发行的7831万股份,占公司总股本的15.53%。至2024年10月31日,华润医药控股有限公司持有的股份总数为1.48亿股,占公司总股本的29.2793%。本次解除限售股份均不存在被质押或冻结的情况。2024年前三季度,博雅生物实现收入12.45亿元,归母净利润4.13亿元。文章来源:财中社博雅生物解除华润医药控股15.53%限售股份","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119183012a2457323&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119183012a2457323&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"2484541999","title":"华润医药11月19日获主力加仓383万元 环比增加378.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484541999","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484541999?lang=zh_cn&edition=full","pubTime":"2024-11-19 16:15","pubTimestamp":1732004159,"startTime":"0","endTime":"0","summary":"11月19日, 华润医药股价跌0.18%,报收5.42元,成交金额3067万元,换手率0.09%,振幅1.47%,量比0.60。华润医药今日主力资金净流入383万元,上一交易日主力净流入80万元,今日环比增加378.75%。该股近5个交易日下跌2.51%,主力资金累计净流入516万元;近20日主力资金累计净流入351万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119161620abcea14c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119161620abcea14c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2484596865","title":"华润医药(03320.HK)治疗角结膜上皮损伤药物通过国家药监局一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2484596865","media":"阿斯达克财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484596865?lang=zh_cn&edition=full","pubTime":"2024-11-19 12:28","pubTimestamp":1731990480,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布,旗下华润紫竹药业收到国家药监局颁发的地夸磷索钠滴眼液《药品补充申请批准通知书》,并视同通过一致性评价,相关药物适用于经诊断为伴随泪液异常的角结膜上皮损伤的干眼患者。据国家药监局信息显示,中国内地境内已批准上市的地夸磷索钠滴眼液生产企业共有29间,均视同通过一致性评价。华润医药表示,上述药物获得《药品补充申请批准通知书》并视同通过一致性评价,将进一步丰富华润医药产品线,有助于提升公司产品的市场竞争力,对集团整体经营产生积极影响。(js/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-18 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1397802/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2483345149","title":"华润医药11月15日遭主力抛售181万元 环比增加4425.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483345149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483345149?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:16","pubTimestamp":1731658607,"startTime":"0","endTime":"0","summary":"11月15日, 华润医药股价跌0.92%,报收5.37元,成交金额3429万元,换手率0.10%,振幅1.85%,量比0.65。华润医药今日主力资金净流出181万元,上一交易日主力净流出4万元,今日环比增加4425.00%。该股近5个交易日下跌5.62%,主力资金累计净流入382万元;近20日主力资金累计净流入923万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115161716abc3e09a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115161716abc3e09a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2483441448","title":"华润医药(03320.HK)旗下利格列汀原料药获化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2483441448","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483441448?lang=zh_cn&edition=full","pubTime":"2024-11-14 16:12","pubTimestamp":1731571920,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 宣布,旗下浙江新赛科收到国家药品监督管理局颁发的利格列汀原料药《化学原料药上市申请批准通知书》(通知书编号:2024YS01146)。利格列汀属于一种高效的选择性二肽基肽酶-4(DPP-4)抑制剂,用于改善2型糖尿病患者的血糖控制。(sl/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-14 12:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1396690/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2483402498","title":"华润医药11月13日主力资金流入237万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483402498","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483402498?lang=zh_cn&edition=full","pubTime":"2024-11-13 16:17","pubTimestamp":1731485828,"startTime":"0","endTime":"0","summary":"11月13日, 华润医药股价跌0.54%,报收5.55元,成交金额5917万元,换手率0.17%,振幅1.97%,量比1.10。华润医药今日主力资金净流入237万元,连续5日净流入,上一交易日主力净流入264万元,今日环比减少10.23%。近一年数据显示,该股主力连续5日净流入后,次日上涨概率为66.67%,平均涨幅为2.14%。该股近5个交易日下跌0.54%,主力资金累计净流入1465万元;近20日主力资金累计净流入1166万元,其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113161742a2332552&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113161742a2332552&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2482577607","title":"华润医药旗下华润堂关闭香港分店,内地业务此前已被分拆","url":"https://stock-news.laohu8.com/highlight/detail?id=2482577607","media":"新京报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482577607?lang=zh_cn&edition=full","pubTime":"2024-11-12 18:17","pubTimestamp":1731406620,"startTime":"0","endTime":"0","summary":"近日,华润医药旗下连锁药店品牌“华润堂”正式关闭香港全线分店。华润堂称,关闭的主要原因是其业务受到外部不确定因素及各种营运挑战的影响。华润三九与华润堂均为中国华润有限公司控制的企业,华润堂此次闭店范围只限于香港区域,华润堂内地业务此前已经分拆,被华润三九收购。记者注意到,华润堂在内地业务被分拆前,其经营状况已然不佳。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112181913a230279b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112181913a230279b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2482242967","title":"华润医药11月12日获主力加仓264万元 环比增加306.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482242967","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482242967?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:16","pubTimestamp":1731399416,"startTime":"0","endTime":"0","summary":"11月12日, 华润医药股价跌0.71%,报收5.58元,成交金额7373万元,换手率0.21%,振幅4.27%,量比1.52。华润医药今日主力资金净流入264万元,连续4日净流入,上一交易日主力净流入65万元,今日环比增加306.15%。近一年数据显示,该股主力连续4日净流入后,次日上涨概率为40.00%,平均涨幅为1.27%。该股近5个交易日下跌1.57%,主力资金累计净流入1072万元;近20日主力资金累计净流入569万元,其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112161939a22facad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112161939a22facad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2482721665","title":"华润医药(03320.HK)旗下氨氯地平阿托伐他汀钙片补充申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2482721665","media":"阿斯达克财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482721665?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:09","pubTimestamp":1731398940,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 宣布,集团旗下华润赛科收到国家药监局颁发的氨氯地平阿托伐他汀钙片《药品补充申请批准通知书》。氨氯地平阿托伐他汀钙片适用于需氨氯地平和阿托伐他汀联合治疗的患者。其中,氨氯地平用于高血压的治疗,用于慢性稳定性心绞痛、血管痉挛性心绞痛及经血管造影证实的冠心病的治疗;阿托伐他汀用于高胆固醇血症及冠心病的治疗。(ha/k)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-12 12:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1395982/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2482725469","title":"光大证券:赋能商业健康险促进支付多元化 医保预付缓解垫资压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2482725469","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482725469?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:29","pubTimestamp":1731396565,"startTime":"0","endTime":"0","summary":"事件:1) 2024 年11 月7 日,国家医保局召开医保平台数据赋能商业健康保险发展座谈会;2) 2024 年11 月11 日,国家医保局办公室 财政部办公厅印发《关于做好医保基金预付工作的通知》。光大证券主要观点如下:全国统一医保系统平台和大数据赋能商业健康保险,推进支付方式多元化进程。医保预付制度提高医保资金使用效率,缓解医疗机构垫资压力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK0183","LU0307460666.USD","01801","BK1583","LU0588546209.SGD","BK1197","LU1969619763.USD","BK0276","BK0028","BK1515","LU2328871848.SGD","BK1191","06178","BK1570","03320","BK1500","LU1115378108.SGD","01099","BK1589","LU2488822045.USD","BK0012","BK1147","BK1161","06160","BK1564","601788","LU0640798160.USD","BK1588"],"gpt_icon":0},{"id":"2482271240","title":"华润医药11月11日主力资金流入65万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2482271240","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482271240?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:16","pubTimestamp":1731313013,"startTime":"0","endTime":"0","summary":"11月11日, 华润医药股价跌1.23%,报收5.62元,成交金额3262万元,换手率0.09%,振幅2.64%,量比0.62。华润医药今日主力资金净流入65万元,连续3日净流入,上一交易日主力净流入238万元,今日环比减少72.69%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为27.27%,平均涨幅为4.87%。该股近5个交易日下跌0.71%,主力资金累计净流入661万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1306万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111161740a22be0ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111161740a22be0ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2481299303","title":"华润医药附属完成收购Green Cross HK的100%权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2481299303","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481299303?lang=zh_cn&edition=full","pubTime":"2024-11-07 08:53","pubTimestamp":1730940780,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 华润医药(03320)发布公告,于国家市场监督管理总局的相关对口部门的股份转让登记已经完成。因此,截至本公告日期,建议收购Green Cross HK 100%股权已根据购股协议的条款及条件完成。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-07/doc-incvexcp7918458.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-11-07/doc-incvexcp7918458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2481567395","title":"华润医药(03320)附属完成收购Green Cross HK的100%权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2481567395","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481567395?lang=zh_cn&edition=full","pubTime":"2024-11-06 18:20","pubTimestamp":1730888451,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布公告,于国家市场监督管理总局的相关对口部门的股份转让登记已经完成。因此,截至本公告日期,建议收购Green Cross HK 100%股权已根据购股协议的条款及条件完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2479773061","title":"华润医药10月31日主力资金流出130万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2479773061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479773061?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:15","pubTimestamp":1730362552,"startTime":"0","endTime":"0","summary":"10月31日, 华润医药股价跌1.26%,报收5.50元,成交金额5811万元,换手率0.17%,振幅2.87%,量比1.31。华润医药今日主力资金净流出130万元,连续3日净流出,上一交易日主力净流出220万元,今日环比减少40.91%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为52.63%,平均跌幅为1.81%。该股近5个交易日下跌5.05%,主力资金累计净流出201万元;近20日主力资金累计净流出2501万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031161623a200555a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031161623a200555a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","03320","BK1191"],"gpt_icon":0},{"id":"2479755069","title":"华润医药(03320.HK)附属东阿阿胶首九个月赚11.52亿人民币 增长46.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479755069","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479755069?lang=zh_cn&edition=full","pubTime":"2024-10-31 02:43","pubTimestamp":1730313780,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布,附属东阿阿胶首九个月业绩,营业总收入43.29亿人民币,按年增加26.3%。录得净利润11.52亿人民币,增长46.7%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-30 16:25。)过往派息公布日期派息事项派息内容2024/08/29中期业绩普通股息:人民币 0.083 (相当于港元 0.0908)2024/03/26末期业绩普通股息:人民币 0.154 (相当于港元 0.1697)2023/10/31第三季业绩无派息2023/08/31中期业绩无派息AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180322103035593_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180322103035593_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1392626/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03320","BK1191","BK1570","BK0175","BK0188","BK0196","BK0010","BK0187","BK0239","SG9999014674.SGD","BK0028","000423","BK0183"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":-0.0354},{"period":"1month","weight":-0.116},{"period":"3month","weight":-0.0237},{"period":"6month","weight":-0.1126},{"period":"1year","weight":0.0255},{"period":"ytd","weight":0.0276}],"compareEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0737},{"period":"3month","weight":0.0919},{"period":"6month","weight":0.0334},{"period":"1year","weight":0.0736},{"period":"ytd","weight":0.128}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.008478},{"month":2,"riseRate":0.75,"avgChangeRate":0.055041},{"month":3,"riseRate":0.5,"avgChangeRate":-0.02417},{"month":4,"riseRate":0.875,"avgChangeRate":0.053308},{"month":5,"riseRate":0.5,"avgChangeRate":0.006748},{"month":6,"riseRate":0.375,"avgChangeRate":0.006122},{"month":7,"riseRate":0.125,"avgChangeRate":-0.056809},{"month":8,"riseRate":0.5,"avgChangeRate":0.011562},{"month":9,"riseRate":0.25,"avgChangeRate":-0.023565},{"month":10,"riseRate":0.125,"avgChangeRate":-0.03496},{"month":11,"riseRate":0.444444,"avgChangeRate":0.014217},{"month":12,"riseRate":0.5,"avgChangeRate":-0.002995}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}